About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5553469
Allelic
Composition
Tg(JAK2*V617F)FF1Rsko/0
Commd10Tg(Vav1-icre)A2Kio/Commd10+
Genetic
Background
involves: C57BL/6 * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Commd10Tg(Vav1-icre)A2Kio mutation (3 available); any Commd10 mutation (24 available)
Tg(JAK2*V617F)FF1Rsko mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• colony assays of progenitors show extramedullary hematopoiesis with markedly increased erythroid and myeloid progenitor numbers in spleen
• bones are pale at 20 weeks of age, suggesting decreased erythropoiesis
• erythroid TER-119+ cells are reduced in the bone marrow but a compensatory increase is seen in the spleen at 20 weeks of age
• myeloid cells are the predominant cell population in the bone marrow and are increased in the spleen at 20 weeks of age
• liver shows extramedullary hematopoiesis at 20 weeks of age with highly atypical megakaryocytes, but islands with myelopoeisis and erythropoiesis are also seen
• colony assays of progenitors show extramedullary hematopoiesis with markedly increased erythroid and myeloid progenitor numbers in spleen
• hematopoietic cells, including megakaryocytes are seen in the lung at 20 weeks of age
• bone marrow shows hypercellularity with trilineage hyperplasia at 20 weeks of age
• increase in numbers of megakaryocytes in the spleen and bone marrow at 20 weeks of age, most with morphological abnormalities such as hyperchromatic, hyperlobulated nuclei, and bizarre nuclear configuration, and often forming clusters
• colony assays of progenitors show extramedullary hematopoiesis with markedly increased erythroid and myeloid progenitor numbers in spleen
• collagen-based culture indicates a small increase in CFU-MK in bone marrow and a massive expansion of CFU-MK in the spleen
• slight decrease in hemoglobin at 20 weeks of age but is normal at 10 weeks of age
• slight increase in neutrophils at 10 and 20 weeks of age
• thrombocytosis is seen at 10 weeks of age, with a massive increase in platelets at 20 weeks of age
• the relative amount of B and T cells in the spleen and bone marrow is reduced at 20 weeks of age
• the relative amount of B and T cells in the spleen and bone marrow is reduced at 20 weeks of age
• destruction of normal splenic architecture by atypical hematopoiesis is seen in some sections of the spleen at 20 weeks of age
• seen at 20 weeks of age

immune system
• myeloid cells are the predominant cell population in the bone marrow and are increased in the spleen at 20 weeks of age
• slight increase in neutrophils at 10 and 20 weeks of age
• the relative amount of B and T cells in the spleen and bone marrow is reduced at 20 weeks of age
• the relative amount of B and T cells in the spleen and bone marrow is reduced at 20 weeks of age
• destruction of normal splenic architecture by atypical hematopoiesis is seen in some sections of the spleen at 20 weeks of age
• seen at 20 weeks of age

skeleton
• dilated sinusoids with intrasinusoidal hematopoiesis are seen in the bone marrow at 20 weeks of age
• myeloid cells are the predominant cell population in the bone marrow
• presence of myelofibrosis at 20 weeks of age

growth/size/body

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
essential thrombocythemia DOID:2224 OMIM:187950
OMIM:601977
OMIM:614521
J:134364


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory